Travelers' diarrhea

Alexander K.C. Leung, William Lane M. Robson, Herbert Dele Davies

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Travelers' diarrhea is common. Between 8% and 50% of travelers develop diarrhea; incidence depends on the country visited. The attack rate is highest for travelers from a developed country who visit a developing country. Children are at particular risk. Travelers' diarrhea is usually acquired through ingestion of fecally contaminated food and water. Most cases are due to a bacterial pathogen, commonly, Escherichia coli, and occur within the first few days after arrival in a foreign country. More than 90% of episodes develop within the first 2 wk of initiation of travel. Dehydration is the most common complication. Water and electrolyte replenishment is important and can usually be accomplished with an oral rehydration solution. Judicious use of an antimotility agent and antimicrobial therapy reduces the duration and severity of diarrhea. Pretravel education on hygiene and on the safe selection of food items is important in minimizing episodes. Dukoral™ (Aventis Pharma Ltd., Auckland, New Zealand) vaccine should be considered for travelers who are 2 y of age or older and who will be visiting an area associated with risk of infection due to enterotoxigenic E coli or Vibrio cholerae. Typhoid vaccine is recommended for travelers who will be visiting areas with poor sanitation and hygiene.

Original languageEnglish (US)
Pages (from-to)519-527
Number of pages9
JournalAdvances in Therapy
Volume23
Issue number4
DOIs
StatePublished - Jul 1 2006

Fingerprint

Diarrhea
Hygiene
Typhoid-Paratyphoid Vaccines
Rehydration Solutions
Enterotoxigenic Escherichia coli
Food Preferences
Sanitation
Vibrio cholerae
Water
Fluid Therapy
Anti-Infective Agents
New Zealand
Dehydration
Developed Countries
Electrolytes
Developing Countries
Vaccines
Eating
Escherichia coli
Education

Keywords

  • Antibiotic
  • Antimotility agent
  • Contaminated food
  • Escherichia coli
  • Oral rehydration
  • Vaccination

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Leung, A. K. C., Robson, W. L. M., & Davies, H. D. (2006). Travelers' diarrhea. Advances in Therapy, 23(4), 519-527. https://doi.org/10.1007/BF02850040

Travelers' diarrhea. / Leung, Alexander K.C.; Robson, William Lane M.; Davies, Herbert Dele.

In: Advances in Therapy, Vol. 23, No. 4, 01.07.2006, p. 519-527.

Research output: Contribution to journalReview article

Leung, AKC, Robson, WLM & Davies, HD 2006, 'Travelers' diarrhea', Advances in Therapy, vol. 23, no. 4, pp. 519-527. https://doi.org/10.1007/BF02850040
Leung, Alexander K.C. ; Robson, William Lane M. ; Davies, Herbert Dele. / Travelers' diarrhea. In: Advances in Therapy. 2006 ; Vol. 23, No. 4. pp. 519-527.
@article{99ff54cedf6241448fe10550285da24f,
title = "Travelers' diarrhea",
abstract = "Travelers' diarrhea is common. Between 8{\%} and 50{\%} of travelers develop diarrhea; incidence depends on the country visited. The attack rate is highest for travelers from a developed country who visit a developing country. Children are at particular risk. Travelers' diarrhea is usually acquired through ingestion of fecally contaminated food and water. Most cases are due to a bacterial pathogen, commonly, Escherichia coli, and occur within the first few days after arrival in a foreign country. More than 90{\%} of episodes develop within the first 2 wk of initiation of travel. Dehydration is the most common complication. Water and electrolyte replenishment is important and can usually be accomplished with an oral rehydration solution. Judicious use of an antimotility agent and antimicrobial therapy reduces the duration and severity of diarrhea. Pretravel education on hygiene and on the safe selection of food items is important in minimizing episodes. Dukoral™ (Aventis Pharma Ltd., Auckland, New Zealand) vaccine should be considered for travelers who are 2 y of age or older and who will be visiting an area associated with risk of infection due to enterotoxigenic E coli or Vibrio cholerae. Typhoid vaccine is recommended for travelers who will be visiting areas with poor sanitation and hygiene.",
keywords = "Antibiotic, Antimotility agent, Contaminated food, Escherichia coli, Oral rehydration, Vaccination",
author = "Leung, {Alexander K.C.} and Robson, {William Lane M.} and Davies, {Herbert Dele}",
year = "2006",
month = "7",
day = "1",
doi = "10.1007/BF02850040",
language = "English (US)",
volume = "23",
pages = "519--527",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "4",

}

TY - JOUR

T1 - Travelers' diarrhea

AU - Leung, Alexander K.C.

AU - Robson, William Lane M.

AU - Davies, Herbert Dele

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Travelers' diarrhea is common. Between 8% and 50% of travelers develop diarrhea; incidence depends on the country visited. The attack rate is highest for travelers from a developed country who visit a developing country. Children are at particular risk. Travelers' diarrhea is usually acquired through ingestion of fecally contaminated food and water. Most cases are due to a bacterial pathogen, commonly, Escherichia coli, and occur within the first few days after arrival in a foreign country. More than 90% of episodes develop within the first 2 wk of initiation of travel. Dehydration is the most common complication. Water and electrolyte replenishment is important and can usually be accomplished with an oral rehydration solution. Judicious use of an antimotility agent and antimicrobial therapy reduces the duration and severity of diarrhea. Pretravel education on hygiene and on the safe selection of food items is important in minimizing episodes. Dukoral™ (Aventis Pharma Ltd., Auckland, New Zealand) vaccine should be considered for travelers who are 2 y of age or older and who will be visiting an area associated with risk of infection due to enterotoxigenic E coli or Vibrio cholerae. Typhoid vaccine is recommended for travelers who will be visiting areas with poor sanitation and hygiene.

AB - Travelers' diarrhea is common. Between 8% and 50% of travelers develop diarrhea; incidence depends on the country visited. The attack rate is highest for travelers from a developed country who visit a developing country. Children are at particular risk. Travelers' diarrhea is usually acquired through ingestion of fecally contaminated food and water. Most cases are due to a bacterial pathogen, commonly, Escherichia coli, and occur within the first few days after arrival in a foreign country. More than 90% of episodes develop within the first 2 wk of initiation of travel. Dehydration is the most common complication. Water and electrolyte replenishment is important and can usually be accomplished with an oral rehydration solution. Judicious use of an antimotility agent and antimicrobial therapy reduces the duration and severity of diarrhea. Pretravel education on hygiene and on the safe selection of food items is important in minimizing episodes. Dukoral™ (Aventis Pharma Ltd., Auckland, New Zealand) vaccine should be considered for travelers who are 2 y of age or older and who will be visiting an area associated with risk of infection due to enterotoxigenic E coli or Vibrio cholerae. Typhoid vaccine is recommended for travelers who will be visiting areas with poor sanitation and hygiene.

KW - Antibiotic

KW - Antimotility agent

KW - Contaminated food

KW - Escherichia coli

KW - Oral rehydration

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=33750988200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750988200&partnerID=8YFLogxK

U2 - 10.1007/BF02850040

DO - 10.1007/BF02850040

M3 - Review article

VL - 23

SP - 519

EP - 527

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 4

ER -